Clinical trials in acute respiratory distress syndrome: challenges and opportunities.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Lancet Respiratory Medicine

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S2213-2600(17)30188-1PMID 28664851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome

  2017cited by this paper
• Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome*

  2017cited by this paper
• Clinical Predictors of Hospital Mortality Differ Between Direct and Indirect ARDS

  2017cited by this paper
• Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis

  2017cited by this paper
• Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome

  2017cited by this paper
• Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome

  2017cited by this paper
• Volume Delivered During Recruitment Maneuver Predicts Lung Stress in Acute Respiratory Distress Syndrome*

  2016cited by this paper
• Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial Design.

  2016cited by this paper
• Sepsis: pathophysiology and clinical management

  2016cited by this paper
• Cell-free hemoglobin: a novel mediator of acute lung injury.

  2016cited by this paper
• Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study.

  2016cited by this paper
• Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction following Trauma or Sepsis

  2016cited by this paper
• Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.

  2016cited by this paper
• Clinical, Radiographic, Physiologic, and Biologic Measurements to Facilitate Personalized Medicine for ARDS.

  2016cited by this paper
• Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial.

  2016cited by this paper
• Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers

  2016cited by this paper
• Timing of Intubation and Clinical Outcomes in Adults With Acute Respiratory Distress Syndrome*

  2016cited by this paper
• Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy

  2016cited by this paper
• Elevated Plasma Levels of sRAGE Are Associated With Nonfocal CT-Based Lung Imaging in Patients With ARDS: A Prospective Multicenter Study.

  2016cited by this paper
• High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.

  2015cited by this paper
• Who cares about preventing acute respiratory distress syndrome?

  2015cited by this paper
• Title : How outcomes are defined in clinical trials of mechanically ventilated adults and children 2

  2015cited by this paper
• The Adult Calfactant in Acute Respiratory Distress Syndrome Trial.

  2015cited by this paper
• Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis

  2015cited by this paper
• Platelets in the pathogenesis of acute respiratory distress syndrome.

  2015cited by this paper
• Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care.

  2015cited by this paper
• Randomized, Placebo-Controlled Trial of Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis: The Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis Trial*

  2015cited by this paper
• Prehospital Aspirin Use Is Associated With Reduced Risk of Acute Respiratory Distress Syndrome in Critically Ill Patients: A Propensity-Adjusted Analysis*

  2015cited by this paper
• Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

  2015cited by this paper
• One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome

  2014cited by this paper
• Rosuvastatin for sepsis-associated acute respiratory distress syndrome.

  2014cited by this paper
• How outcomes are defined in clinical trials of mechanically ventilated adults and children.

  2014cited by this paper
• Simvastatin in the acute respiratory distress syndrome.

  2014cited by this paper
• Clinical and biological heterogeneity in acute respiratory distress syndrome: direct versus indirect lung injury.

  2014cited by this paper
• Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies.

  2014cited by this paper
• Steroids for acute respiratory distress syndrome?

  2014cited by this paper
• Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.

  2014cited by this paper
• Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome

  2014cited by this paper
• The Association Between Physiologic Dead-Space Fraction and Mortality in Subjects With ARDS Enrolled in a Prospective Multi-Center Clinical Trial

  2014cited by this paper
• Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis.

  2014cited by this paper
• Erratum: Randomized, placebo-controlled clinical trial of an aerosolized β2-agonist for treatment of acute lung injury (American Journal of Respiratory and Critical Care Medicine (2011) 184 (561-568))

  2013cited by this paper
• Association Between Cell-Free Hemoglobin, Acetaminophen, and Mortality in Patients With Sepsis: An Observational Study*

  2013cited by this paper
• Prone position in acute respiratory distress syndrome. Rationale, indications, and limits.

  2013cited by this paper
• Pharmacological treatments in ARDS; a state-of-the-art update

  2013cited by this paper
• Prone positioning in severe acute respiratory distress syndrome.

  2013cited by this paper
• Response‐adaptive decision‐theoretic trial design: operating characteristics and ethics

  2013cited by this paper
• Early Acute Lung Injury: Criteria for Identifying Lung Injury Prior to the Need for Positive Pressure Ventilation*

  2013cited by this paper
• A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury*

  2012cited by this paper
• The severity of shock is associated with impaired rates of net alveolar fluid clearance in clinical acute lung injury.

  2012cited by this paper
• Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial

  2012cited by this paper
• The acute respiratory distress syndrome: what's in a name?

  2012cited by this paper
• Acute Respiratory Distress Syndrome The Berlin Definition

  2012cited by this paper
• CARING FOR THE CRITICALLY ILL PATIENT

  2011cited by this paper
• Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.

  2011cited by this paper
• Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study.

  2011cited by this paper
• Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury.

  2010cited by this paper
• Prone positioning improves survival in severe ARDS: a pathophysiologic review and individual patient meta-analysis.

  2010cited by this paper
• Neuromuscular blockers in early acute respiratory distress syndrome.

  2010cited by this paper
• Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure

  2010cited by this paper
• Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome

  2009cited by this paper
• Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury.

  2009cited by this paper
• Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial.

  2009cited by this paper
• Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure.

  2009cited by this paper
• A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome*

  2009cited by this paper
• Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.

  2009cited by this paper
• Randomized clinical trial of activated protein C for the treatment of acute lung injury.

  2008cited by this paper
• Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial.

  2008cited by this paper
• Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis

  2007cited by this paper
• A multiple‐center survey on the use in clinical practice of noninvasive ventilation as a first‐line intervention for acute respiratory distress syndrome*

  2007cited by this paper
• Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders*

  2007cited by this paper
• Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury.

  2006cited by this paper
• Comparison of two fluid-management strategies in acute lung injury.

  2006cited by this paper
• A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome.

  2006cited by this paper
• Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.

  2006cited by this paper
• Lung recruitment in patients with the acute respiratory distress syndrome.

  2006cited by this paper
• Bayesian clinical trials

  2006cited by this paper
• Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality.

  2005cited by this paper
• Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome*

  2004cited by this paper
• Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial.

  2004cited by this paper
• Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome.

  2004cited by this paper
• Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial.

  2004cited by this paper
• Neutrophil elastase inhibition in acute lung injury: Results of the STRIVE study

  2004cited by this paper
• Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome.

  2002cited by this paper
• Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome

  2002cited by this paper
• Effect of prone positioning on the survival of patients with acute respiratory failure.

  2001cited by this paper
• Pulmonary and extrapulmonary forms of acute respiratory distress syndrome.

  2001cited by this paper
• Regional distribution of gas and tissue in acute respiratory distress syndrome. II. Physiological correlations and definition of an ARDS Severity Score

  2000cited by this paper
• Predictors of mortality in acute respiratory distress syndrome. Focus On the role of right heart catheterization.

  2000cited by this paper
• Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network.

  2000cited by this paper
• Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

  2000cited by this paper
• The acute respiratory distress syndrome.

  2000cited by this paper
• Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.

  1999cited by this paper
• Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients.

  1999cited by this paper
• Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.

  1998cited by this paper
• A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group.

  1997cited by this paper
• The acute respiratory distress syndrome.

  1996cited by this paper
• The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

  1994cited by this paper
• An expanded definition of the adult respiratory distress syndrome.

  1988cited by this paper
• High-dose corticosteroids in patients with the adult respiratory distress syndrome.

  1987cited by this paper
• Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome.

  1985cited by this paper

• Enhanced Uptake and Retention of an Acidic Sophorolipid Delivery System Boosts Acute Lung Injury Therapy.

  2026cites this paper
• Targeting CD73 and correcting adenosinergic signaling in critically ill patients

  2026cites this paper
• Overexpression of IL-8 augments the susceptibility to a hyperinflammatory phenotype in pediatric acute respiratory distress syndrome and correlates with adverse outcomes: a retrospective two-center study conducted in northwest China.

  2026cites this paper
• MicroRNA‐223/NE Signaling Pathway Inhibits Lipopolysaccharide‐Induced Acute Lung Injury by Regulating Neutrophil Extracellular Traps

  2026cites this paper
• Smart nebulized ROS-responsive hydrogel microspheres loaded with UC-MSCs-derived exosomes for the treatment of acute lung injury

  2026cites this paper
• Longitudinal multiomic signatures of ARDS and sepsis inflammatory phenotypes identify pathways associated with mortality

  2025cites this paper
• Enhancing Lung Recovery: Inhaled Poly(lactic-co-glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology

  2025cites this paper
• The Global Definition and the Future of ARDS Research

  2025cites this paper
• Sepsis subphenotypes: bridging the gaps in sepsis treatment strategies

  2025cites this paper
• Regulation of cGAS-STING pathway with inhalable nanozyme in acute lung injury.

  2025cites this paper
• Mannose-6-phosphate attenuates acute lung injury by competitive release of acid sphingomyelinase from the mannose-6-phosphate receptor in endothelial caveolae

  2025cites this paper
• Diagnostic biomarkers and miRNAs in prognosis of acute respiratory distress syndrome.

  2025cites this paper
• Machine learning-based identification of efficient and restrictive physiological subphenotypes in acute respiratory distress syndrome

  2025cites this paper
• FRAIL PARTICIPANTS IN RANDOMIZED CONTROLLED TRIALS OF ACUTE RESPIRATORY DISTRESS SYNDROME

  2025cites this paper
• Disease–Drug–Drug Interaction of Imatinib in COVID‐19 ARDS: A Pooled Population Pharmacokinetic Analysis

  2025cites this paper
• Rutin ameliorates LPS-induced acute lung injury in mice by inhibiting the cGAS-STING-NLRP3 signaling pathway

  2025cites this paper
• Advanced nanotherapies for precision treatment of inflammatory lung diseases

  2025cites this paper
• Longitudinal multi-omic signatures of ARDS and sepsis inflammatory phenotypes identify key pathways associated with mortality

  2025cites this paper
• Efficacy and safety of imatinib in patients with COVID-19: a systematic review and meta-analysis

  2025cites this paper
• Clinical Implications of Systemic Corticosteroid Treatment on Mortality and Surgical Outcomes in Patients with Gastrointestinal Perforation: A Retrospective Cohort Study

  2025cites this paper
• Phillyrin for sepsis-related acute lung injury: A potential strategy suppressing GSK-3β.

  2025cites this paper
• Prone Positioning to Improve Cerebral Oxygenation in Patients With Acute Respiratory Distress Syndrome.

  2025cites this paper
• Therapeutic Aspects of Melatonin-sirtuin Crosstalk: An Updated Review of Current Data Based on Cellular Mechanisms.

  2025cites this paper
• Tri-specific molecularly imprinted lysosomal nanodegrader enables synergistic therapy of cytokine storm

  2025cites this paper
• Neutrophil-specific Shp1 loss results in lethal pulmonary hemorrhage in mouse models of acute lung injury

  2024cites this paper
• Loss of neutrophil Shp1 produces hemorrhagic and lethal acute lung injury

  2024cites this paper
• Exploration of key mechanisms underlying the therapeutic effects of AMD3100 on attenuating lipopolysaccharide-induced acute lung injury in mice

  2024cites this paper
• Naringin dihydrochalcone alleviates sepsis-induced acute lung injury via improving gut microbial homeostasis and activating GPR18 receptor.

  2024cites this paper
• Subphenotypes in Acute Respiratory Distress Syndrome: Universal Steps Toward Treatable Traits.

  2024cites this paper
• siRNA Nanoparticle Dry Powder Formulation with High Transfection Efficiency and Pulmonary Deposition for Acute Lung Injury Treatment.

  2024cites this paper
• Environmental Risk Factors for Acute Respiratory Distress Syndrome.

  2024cites this paper
• Cellular Mechanisms of Lung Injury: Current Perspectives.

  2024cites this paper
• Role of the receptor for advanced glycation end products in the severity of SARS-CoV-2 infection in diabetic patients

  2024cites this paper
• Temporal Transitions of the Hyperinflammatory and Hypoinflammatory Phenotypes in Critical Illness.

  2024cites this paper
• A phytomedicine extract exerts an anti-inflammatory response in the lungs by reducing STING-mediated type I interferon release.

  2024cites this paper
• Huangqi Baihe Granules alleviate hypobaric hypoxia-induced acute lung injury in rats by suppressing oxidative stress and the TLR4/NF-κB/NLRP3 inflammatory pathway.

  2024cites this paper
• Molecular Phenotypes of ARDS in the ROSE Trial have Differential Outcomes and Gene Expression Patterns That Differ at Baseline and Longitudinally Over Time.

  2024cites this paper
• Rapidly improving ARDS differs clinically and biologically from persistent ARDS

  2024cites this paper
• Future directions of lung‐protective ventilation strategies in acute respiratory distress syndrome

  2024cites this paper
• Control of inflammatory lung injury and repair by metabolic signaling in endothelial cells

  2024cites this paper
• Personalized mechanical ventilation guided by ultrasound in patients with acute respiratory distress syndrome (PEGASUS): study protocol for an international randomized clinical trial

  2024cites this paper
• Clinical and biologic profiles of patients with acute respiratory distress syndrome by prevalence of chronic obstructive pulmonary disease or emphysema; a cohort study

  2024cites this paper
• Liraglutide Pretreatment Attenuates Sepsis-Induced Acute Lung Injury.

  2023cites this paper
• Targeted Delivery of the Pan‐Inflammasome Inhibitor MM01 as an Alternative Approach to Acute Lung Injury Therapy

  2023cites this paper
• Early plasma proteomic biomarkers and prediction model of acute respiratory distress syndrome after cardiopulmonary bypass: a prospective nested cohort study

  2023cites this paper
• Exposure to ambient air pollutants and acute respiratory distress syndrome risk in sepsis

  2023cites this paper
• AMPK activation improves recovery from pneumonia-induced lung injury via reduction of er-stress and apoptosis in alveolar epithelial cells

  2023cites this paper
• Tetramethylpyrazine ameliorates endotoxin-induced acute lung injury by relieving Golgi stress via the Nrf2/HO-1 signaling pathway

  2023cites this paper
• Personalized ventilatory strategy based on lung recruitablity in COVID-19-associated acute respiratory distress syndrome: a prospective clinical study

  2023cites this paper
• NETs Promote Inflammatory Injury by Activating cGAS-STING Pathway in Acute Lung Injury

  2023cites this paper
• Protective effect of liriodendrin on IgG immune complex-induced acute lung injury via inhibiting SRC/STAT3/MAPK signaling pathway: a network pharmacology research

  2023cites this paper
• The role of the alveolar epithelial glycocalyx in acute respiratory distress syndrome.

  2023cites this paper
• Advancing Precision Medicine for the Diagnosis and Treatment of Acute Respiratory Distress Syndrome

  2023cites this paper
• Association of vasopressors with mortality in critically ill patients with COVID-19: a systematic review and meta-analysis

  2023cites this paper
• A study of the role of myeloid-derived growth factor on acute lung injury in vitro and In vivo

  2023cites this paper
• Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial

  2023cites this paper
• Pulmonary drug delivery for acute respiratory distress syndrome

  2023cites this paper
• Integrin-Dependent Cell–Matrix Adhesion in Endothelial Health and Disease

  2023cites this paper
• Development and validation of primary graft dysfunction predictive algorithm for lung transplant candidates.

  2023cites this paper
• Pharmacologic Treatments in Acute Respiratory Failure.

  2023cites this paper
• Molybdenum Nanodots for Acute Lung Injury Therapy.

  2023cites this paper
• Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19.

  2023cites this paper
• Patient phenotypes and their relation to TNFα signaling and immune cell composition in critical illness and autoimmune disease

  2023cites this paper
• Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic

  2023cites this paper
• Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials.

  2023cites this paper
• Insulin reverses impaired alveolar fluid clearance in ARDS by inhibiting LPS-induced autophagy and inflammatory

  2023cites this paper
• Significance of Pyroptosis in Immunoregulation and Prognosis of Patients with Acute Respiratory Distress Syndrome: Evidence from RNA-Seq of Alveolar Macrophages

  2023cites this paper
• Experiencia y revisión de la literatura del uso del dispositivo Anesthetic Conserving Device (AnaConDa) durante la pandemia en pacientes con neumonía por COVID-19 en un hospital público

  2023cites this paper
• Anti-Inflammatory Effect of L-carvone on Lipopolysaccharide-Induced Acute Lung Injury

  2023influential citation
• Bisdemethoxycurcumin alleviates LPS-induced acute lung injury via activating AMPKα pathway

  2023cites this paper
• Physiological and clinical variables identify ARDS classes and therapeutic heterogeneity to glucocorticoids: a retrospective study

  2023cites this paper
• Rabeprazole Promotes Vascular Repair and Resolution of Sepsis-Induced Inflammatory Lung Injury through HIF-1α

  2022cites this paper
• Acute Respiratory Distress Syndrome after In-Hospital Cardiac Arrest.

  2022cites this paper
• Design and Rationale of the Sevoflurane for Sedation in Acute Respiratory Distress Syndrome (SESAR) Randomized Controlled Trial

  2022cites this paper
• Imatinib Alleviates Lung Injury and Prolongs Survival in Ventilated Rats.

  2022cites this paper
• NEDD9 provides mechanistic insight into the coagulopathy of COVID‐19

  2022cites this paper
• Macrophage-Targeted Nanomedicines for ARDS/ALI: Promise and Potential

  2022cites this paper
• SNP–SNP Interactions of Surfactant Protein Genes in Persistent Respiratory Morbidity Susceptibility in Previously Healthy Children

  2022cites this paper
• A BAYESIAN MACHINE LEARNING APPROACH FOR ESTIMATING HETEROGENEOUS SURVIVOR CAUSAL EFFECTS: APPLICATIONS TO A CRITICAL CARE TRIAL.

  2022cites this paper
• The Future of Clinical Trials Methodology: Accomplishments and Challenges Ahead.

  2022cites this paper
• Promising Treatments for Acute Respiratory Distress Syndrome Associated with Covid-19

  2022cites this paper
• Punicalagin suppresses inflammation in ventilator‐induced lung injury through protease‐activated receptor‐2 inhibition‐induced inhibition of NLR family pyrin domain containing‐3 inflammasome activation

  2022cites this paper
• [Correlation between dead space fraction and pulmonary ultrasound score in patients with acute respiratory distress syndrome and its prognostic value].

  2022cites this paper
• Emodin Protects Against Lipopolysaccharide-Induced Acute Lung Injury via the JNK/Nur77/c-Jun Signaling Pathway

  2022cites this paper
• The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19

  2022cites this paper
• ADAM8 signaling drives neutrophil migration and ARDS severity

  2022cites this paper
• Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases

  2022cites this paper
• Analysis of predictors of mortality and clinical outcomes of different subphenotypes for moderate-to-severe pediatric acute respiratory distress syndrome: A prospective single-center study

  2022cites this paper
• Gene Therapy for Acute Respiratory Distress Syndrome

  2022influential citation
• Deep Learning Chest CT for Clinically Precise Prediction of Sepsis-Induced Acute Respiratory Distress Syndrome: A Protocol for an Observational Ambispective Cohort Study

  2022cites this paper
• Kinase signaling as a drug target modality for regulation of vascular hyperpermeability: a case for ARDS therapy development.

  2022cites this paper
• Omicron in pregnancy: time to breathe easier?

  2022cites this paper
• Biological Phenotyping in Sepsis and Acute Respiratory Distress Syndrome.

  2022cites this paper
• Berberine Ameliorates Inflammation in Acute Lung Injury via NF-κB/Nlrp3 Signaling Pathway

  2022cites this paper
• Respiratory Subsets in Patients with Moderate to Severe Acute Respiratory Distress Syndrome for Early Prediction of Death

  2022cites this paper
• “Rogue” neutrophil-subset [DEspR+CD11b+/CD66b+] immunotype is an actionable therapeutic target for neutrophilic inflammation-mediated tissue injury – studies in human, macaque and rat LPS-inflammation models

  2022influential citation
• RETRACTED ARTICLE: Rubusoside relieves lipopolysaccharide-induced acute lung injury via modulating inflammatory responses: in vitro and in vivo studies

  2022cites this paper
• Hybrid Biomimetic Nanovesicles to Drive High Lung Biodistribution and Prevent Cytokine Storm for ARDS Treatment.

  2022cites this paper
• Opportunities for improved clinical trial designs in acute respiratory distress syndrome.

  2022cites this paper
• ARDS in the time of corona: context and perspective

  2022cites this paper